BioSpace News Archive

Business

Aethlon Medical Announces Third Quarter 2020 Financial Results and Provides Corporate Update

Aethlon Medical, Inc., a medical device therapeutic company focused on developing products to diagnose and treat life and organ threatening diseases, reported financial results for its third quarter ended December 31, 2020 and provided an update on recent developments.

February 10, 2021

·

11 min read

Business

Seagen and Genmab Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer

Seagen Inc. (Nasdaq: SGEN) and Genmab A/S (Nasdaq: GMAB) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for tisotumab vedotin.

February 10, 2021

·

11 min read

Business

Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion

— Chris Lowe Promoted to Chief Operating Officer and Chief Financial Officer — Ted Monohon Promoted to Chief Accounting Officer —Drew Sukovich, Ph.D., RAC, Joins as Vice President, Regulatory and Quality

February 10, 2021

·

6 min read

Core One Labs Prepares First in Series of Patent Applications

Core One Labs Inc. a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce preparations for filing a patent application encompassing its proprietary biosynthetic psilocybin production system.

February 10, 2021

·

4 min read

BiondVax Announces Exercise in Full of Underwriter’s Over-Allotment Option in Follow-on Offering

BiondVax Pharmaceuticals Ltd. today announced that the underwriter of its recent follow-on underwritten offering fully exercised its over-allotment option to purchase 365,217 of BiondVax’s American Depositary Shares (“ADS”).

February 10, 2021

·

4 min read

Business

Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2020

Improves full year profitability and achieves breakeven free cash flow Turns North America segment profitable for the year Provides 2021 guidance and outlook

February 10, 2021

·

34 min read

Pharm Country

Zoetis Declares Second Quarter 2021 Dividend

The Board of Directors of Zoetis Inc . (NYSE:ZTS) has declared a second quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Tuesday, June 1, 2021, to holders of record on Wednesday, April 21, 2021.

February 10, 2021

·

2 min read

Deals

Centene Corporation Prices Offering of Senior Notes - Feb 10, 2021

Centene Corporation announced that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 2.50% senior notes due 2031.

February 10, 2021

·

12 min read

Bio NC

Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial

Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a Series A investment of $2.5 million with Spectrum Financial.

February 10, 2021

·

4 min read

Pharm Country

Scopus BioPharma Announces Closing of Underwriters’ Over-Allotment Option in Full

Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters’ over-allotment option in full, bringing total follow-on public offering proceeds to $10.35 million.

February 10, 2021

·

3 min read